This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers in Australia have created an innovative drug delivery system that utilises a metalbiomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. Any additional, non-functional components in carriers can potentially increase toxicity, Dr Xu shared.
Award-winning health and wellness advertising agency AbelsonTaylor Group received the inaugural ACE Aspire Award for its employee Psychological Safety Initiative from the Healthcare Businesswomen’s Association (HBA). In 2022, AbelsonTaylor developed and implemented a large-scale, ongoing Psychological Safety initiative for its 300 employees.
Introducing new networks and features. What is unique about Clubhouse from other social networks, like Twitter and Facebook, is it is a ‘closed, hierarchical platform’ – a moderator oversees the discussion and possesses the ability to allow someone to either enter in conversation or boot out if appropriate.
And how can regulators balance timely access with robust safety? In an invited commentary , published in JAME Network Open alongside the Imperial paper, she said: “Over the past decade, the FDA approved oncology drugs twice as fast as the EMA, more often through accelerated pathways, and often prior to study publication.
In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. The study also achieved its primary safety composite outcome with no major adverse events observed. mmHg, compared to a reduction of -1.8
Advocacy groups cite concerns over consumer safety, misinformation, and rising drug prices, fueling bipartisan momentum to reconsider how pharmaceuticals are marketed to the public. Social media advertising : Platforms like LinkedIn, YouTube, and niche HCP networks provide B2B and B2C opportunities.
Articles on Pharma Marketing Network have been tracking this evolution, underscoring how data-informed content can fuel both awareness and behavioral change. Pharma brands featured on Pharma Marketing Network have successfully leveraged this omnichannel mindset to deepen engagement, foster trust, and improve campaign performance.
Table of Contents Sr# Headings 1 Introduction 2 What is a Marketing Network in Pharma? A robust marketing network ensures that the right messages reach healthcare professionals (HCPs) and patients, leading to improved engagement and outcomes. But how can pharma marketers build such networks in a competitive, digital-first world?
Tools from providers like eHealthcare Solutions allow for scalable review processes, speeding up campaign approval without sacrificing safety. To see how pharma teams are responding to these challenges, read more on Pharma Marketing Network. Explore more industry content at Pharma Marketing Network. And its moving fast.
Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.
This is part two of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. That’s how healthcare networks can stay prepared without overextending their capacity.
It’s harder than ever for hospital networks to thrive — today’s healthcare landscape is characterized by shrinking operating margins, rising costs, and labor shortages. Landscape of provider performance benchmarking The landscape of hospital network performance benchmarking can be challenging to navigate.
The Pharma Marketing Network offers deep dives into trends, case studies, and tactical marketing guidance tailored for pharma marketers. These platforms can also monitor FDA press releases, brand safety incidents, and healthcare policy changes in real time. Start by bookmarking reliable, industry-recognized sources.
With platforms like Bing, LinkedIn, and programmatic networks, pharma marketers can scale efforts across search engines and display placements. For more insights into how top pharma companies are adapting to digital-first strategies, check the latest insights on Pharma Marketing Network. Moreover, PPC isnt just about Google Ads.
Maximizing Patient Safety and Sustaining Long Term Quality Through Enhanced Device Surveillance while navigating the EU Regulatory Landscape. The post EU Medical Device Safety Monitoring & Reporting Conference | October 26-28, 2021 | Berlin, Germany and Virtual appeared first on Pharma Marketing Network. REGISTER TODAY.
LinkedIn Ads: The Professional HCP Network LinkedIn is an ideal platform for B2B pharma marketing, offering precise targeting based on job title, specialty, and industry. Best For: Thought leadership, industry networking, and professional event promotions. Avoiding misleading claims that exaggerate efficacy or safety.
For additional insights on pharma digital marketing, visit Pharma Marketing Network. Using platforms like EHSs publisher network or Tap Native , brands can ensure their campaigns are targeted, trustworthy, and compliant. For advanced tracking insights, visit Pharma Marketing Network. Does not make misleading health claims.
Veeva’s industry experts share their predictions about how breaking down silos across clinical, regulatory, safety, and quality teams will benefit patients. Safety will create a single source of truth for content management. Kelly Traverso is vice president of Vault Safety Strategy at Veeva.
Understanding the Basics of Digital Advertising Digital advertising involves promoting your brand online through channels like search engines, social media, and display networks. For example, an ad for Humira should clearly outline potential benefits and direct users to full safety information.
A new study published in The Lancet HIV has demonstrated the safety and efficacy of a new dispersible drug formulation of an immediate-release tablet as a human immunodeficiency virus (HIV) treatment for children. The single fixed dose combination (FDC) contains dolutegravir , abacavir and lamivudine.
For expert pharma marketing insights, visit Pharma Marketing Network. By prioritizing compliance, transparency, and patient safety , pharma brands can avoid ad disapprovals and regulatory fines. Visit Pharma Marketing Network for expert industry insights. Reduced lead generation and wasted marketing budget.
Patient Education Instagram, Facebook, and TikTok help spread disease awareness and medication safety information. The Digital Shift in Healthcare 70% of HCPs use social media for professional purposes , including medical education and networking. For expert pharma marketing insights, visit Pharma Marketing Network.
A single misstepsuch as targeting the wrong audience or omitting safety disclaimers can lead to regulatory violations and ad disapprovals. For expert PPC solutions, visit eHealthcare Solutions , a leading digital ad network for pharma and healthcare brands. For more pharma marketing insights, visit Pharma Marketing Network.
rather than just typing “Xarelto safety.” For examples of industry-leading content, visit the Pharma Marketing Networks Featured Articles. For more strategies built for pharma marketers, explore articles on Pharma Marketing Network. Another major change? Search is now more conversational.
In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation. In conclusion, navigating the regulatory environment of pharmaceutical marketing requires a delicate balance between patient safety and industry innovation.
With ActivSight, surgeons can access critical intraoperative visual data as augmented reality overlays, helping to increase surgical outcomes and patient safety. “As We believe ActivSight will be a game-changer in the operating room by revolutionizing surgical vision and, ultimately, improving surgical care and patient safety.
Sunny White is an editorial advisory board member for the Pharma Marketing Network with hands-on experience helping pharmaceutical marketers elevate their promotional material to meet the unique needs of patients and caregivers while remaining compliant. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products.
For expert insights on pharma digital advertising , visit Pharma Marketing Network. Geo-target medical conferences and hospital networks. Include safety disclaimers For branded drug ads, always mention risks and side effects. Each audience requires different keyword strategies, messaging, and landing pages.
Kumar acknowledged that a comprehensive solution for drug serialisation in ERP systems allow drug manufacturers to monitor these metrics and maintain adherence, “due to its customisable interface, centralised networking capabilities, and automated solutions, which allow pharma businesses to keep up with the always changing standards and laws.”
Example: When advertising a drug like Lyrica , your ad must state potential side effects and direct users to detailed safety information. Use dynamic ad formats, and always emphasize the benefits and safety profile of the drug. This means including important disclaimers, not making misleading claims, and linking to approved resources.
It could be superior efficacy, a better safety profile, or more affordable pricing. Networking with industry influencers and thought leaders can open doors for new collaborations, enhancing the credibility and reach of your product. Develop your ability to inspire and align teams with a shared vision.
Established under the Ministry of Health, the MDA regulates the safety and efficacy of medical devices in the country, making it an essential checkpoint for sales reps. Reps must work closely with regulatory teams to ensure the device complies with MDA standards, including technical specifications, safety certifications, and proper labeling.
In pharma marketing, engagement is crucial because it educates HCPs and patients about new treatments, drug safety, and disease management. Check out more featured articles on Pharma Marketing Network. Personalize Patient Outreach Personalization isnt just for HCPspatients respond better to tailored communication.
The alliance will focus on measures to expedite the clinical programme of NKGen using its autologous NK cell therapy, SNK01, and leveraging its clinical partners and donors’ network. Based in the US, NKGen develops and markets new autologous, allogeneic and CAR-NK NK cell therapies.
a company committed to advancing surgical efficiency and safety, announced that they have received Safer Technologies Program (STeP) designation from the FDA for their surgical device StimSite. “Surgeons are constantly learning new techniques, either robotics or laparoscopic, and safety is always front and center.
Overcoming challenges in patient safety, manufacturing and supply of radiopharmaceuticals As clinical trials progress and the first results are published, companies’ best candidates will emerge in the next five years. Hospital staff must also be protected from radiation while handling the agent.
Research gathered from real-world settings offers invaluable insights into drug efficacy, safety, and patient preferences. The post Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies appeared first on Pharma Marketing Network.
Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio. This includes automation and high-speed manufacturing lines.
The safety profile for rucaparib observed in the clinical trial was consistent with current US and European labels for rucaparib. Thomas’ NHS Foundation Trust and King’s College London, London, UK, and European Network of Gynaecological Oncological Trial (ENGOT) lead of the ATHENA trial for rucaparib.
Highlight topics like disease awareness, drug safety, and lifestyle tips to add value to your audience. The post Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry appeared first on Pharma Marketing Network. Augmented reality (AR) can also be used for interactive educational tools targeting HCPs.
While the complexity of distribution networks makes counterfeit detection difficult, the research highlighted a framework for using smart contracts and distributed ledgers to tackle this problem in the drug supply chain. In conclusion, Kordestani et al.
Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products. Initially published in March 2020, the strategy provides a plan for advancing regulatory science over a five-year period.
As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. appeared first on Pharma Marketing Network.
This is largely due to the FDA’s rigorous approach to the safety of microbiome therapeutics, which has manifested in clinical holds, resulting in delays that have dimmed the enthusiasm in the space in recent times. We lost three years,” says Dr. Susy Hota, infectious disease specialist at University Health Network, University of Toronto.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content